264 related articles for article (PubMed ID: 11303584)
1. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix.
Madeleine MM; Daling JR; Schwartz SM; Shera K; McKnight B; Carter JJ; Wipf GC; Critchlow CW; McDougall JK; Porter P; Galloway DA
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):171-7. PubMed ID: 11303584
[TBL] [Abstract][Full Text] [Related]
2. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.
Daling JR; Madeleine MM; McKnight B; Carter JJ; Wipf GC; Ashley R; Schwartz SM; Beckmann AM; Hagensee ME; Mandelson MT; Galloway DA
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):541-8. PubMed ID: 8827359
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction.
Gravitt PE; Lacey JV; Brinton LA; Barnes WA; Kornegay JR; Greenberg MD; Greene SM; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Zaino R; Hildesheim A
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):95-100. PubMed ID: 11219778
[TBL] [Abstract][Full Text] [Related]
4. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus cervical infection and associated risk factors in a region of Argentina with a high incidence of cervical carcinoma.
Tonon SA; Picconi MA; Zinovich JB; Liotta DJ; Bos PD; Galuppo JA; Alonio LV; Ferreras JA; Teyssié AR
Infect Dis Obstet Gynecol; 1999; 7(5):237-43. PubMed ID: 10524669
[TBL] [Abstract][Full Text] [Related]
6. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ.
Ylitalo N; Josefsson A; Melbye M; Sörensen P; Frisch M; Andersen PK; Sparén P; Gustafsson M; Magnusson P; Pontén J; Gyllensten U; Adami HO
Cancer Res; 2000 Nov; 60(21):6027-32. PubMed ID: 11085523
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study.
Hildesheim A; Han CL; Brinton LA; Kurman RJ; Schiller JT
Obstet Gynecol; 1997 Nov; 90(5):748-54. PubMed ID: 9351758
[TBL] [Abstract][Full Text] [Related]
8. [Cancer of the cervix, papillomavirus, contraception and tobacco].
Thiry L; Vokaer R; Detremmerie O; De Schepper N; Herzog A; Bollen A
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(5):477-86. PubMed ID: 8228010
[TBL] [Abstract][Full Text] [Related]
9. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
[TBL] [Abstract][Full Text] [Related]
10. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).
Castle PE; Hillier SL; Rabe LK; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Burk RD; Rodriguez AC; Alfaro M; Hutchinson ML; Morales J; Schiffman M
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1021-7. PubMed ID: 11588127
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control.
Giuliano AR; Papenfuss M; Abrahamsen M; Denman C; de Zapien JG; Henze JL; Ortega L; Brown de Galaz EM; Stephan J; Feng J; Baldwin S; Garcia F; Hatch K
Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1129-36. PubMed ID: 11700260
[TBL] [Abstract][Full Text] [Related]
12. A population-based study of squamous cell vaginal cancer: HPV and cofactors.
Daling JR; Madeleine MM; Schwartz SM; Shera KA; Carter JJ; McKnight B; Porter PL; Galloway DA; McDougall JK; Tamimi H
Gynecol Oncol; 2002 Feb; 84(2):263-70. PubMed ID: 11812085
[TBL] [Abstract][Full Text] [Related]
13. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
[TBL] [Abstract][Full Text] [Related]
14. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys.
Vaccarella S; Herrero R; Dai M; Snijders PJ; Meijer CJ; Thomas JO; Hoang Anh PT; Ferreccio C; Matos E; Posso H; de Sanjosé S; Shin HR; Sukvirach S; Lazcano-Ponce E; Ronco G; Rajkumar R; Qiao YL; Muñoz N; Franceschi S
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2148-53. PubMed ID: 17119039
[TBL] [Abstract][Full Text] [Related]
15. Use of a hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus.
Serwadda D; Wawer MJ; Shah KV; Sewankambo NK; Daniel R; Li C; Lorincz A; Meehan MP; Wabwire-Mangen F; Gray RH
J Infect Dis; 1999 Oct; 180(4):1316-9. PubMed ID: 10479163
[TBL] [Abstract][Full Text] [Related]
16. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas.
Lacey JV; Brinton LA; Abbas FM; Barnes WA; Gravitt PE; Greenberg MD; Greene SM; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Silverberg SG; Hildesheim A
Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1079-85. PubMed ID: 10613340
[TBL] [Abstract][Full Text] [Related]
17. The relationship between human papillomavirus and Epstein-Barr virus infections in relation to age of patients with cervical adenocarcinoma.
Lau HY; Twu NF; Chen PC; Lai CR; Juang CM; Yen MS; Chao KC
Taiwan J Obstet Gynecol; 2009 Dec; 48(4):370-4. PubMed ID: 20045757
[TBL] [Abstract][Full Text] [Related]
18. Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma.
Struijk L; Hall L; van der Meijden E; Wanningen P; Bavinck JN; Neale R; Green AC; Ter Schegget J; Feltkamp MC
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):529-35. PubMed ID: 16537712
[TBL] [Abstract][Full Text] [Related]
19. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
Hansson BG; Rosenquist K; Antonsson A; Wennerberg J; Schildt EB; Bladström A; Andersson G
Acta Otolaryngol; 2005 Dec; 125(12):1337-44. PubMed ID: 16303684
[TBL] [Abstract][Full Text] [Related]
20. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand.
Sukvirach S; Smith JS; Tunsakul S; Muñoz N; Kesararat V; Opasatian O; Chichareon S; Kaenploy V; Ashley R; Meijer CJ; Snijders PJ; Coursaget P; Franceschi S; Herrero R
J Infect Dis; 2003 Apr; 187(8):1246-56. PubMed ID: 12696004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
